Alexion Pharmaceuticals
Mary Goode is an accomplished professional in the biotechnology industry, currently serving as an Associate Director of Process Engineering at Alexion Pharmaceuticals, Inc. since October 2020. Previously, Mary held various key positions, including Principal Engineer at Amgen from October 2017 to September 2019, and Principal Process Scientist at Bristol-Myers Squibb from June 2016 to September 2017. Earlier roles include serving as the formulation line owner at Amgen and as a Process Engineer at Pfizer. Mary earned a Bachelor's degree in Biotechnology from Dublin City University between 1997 and 2001.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
45 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.